Get the tools used by (smart)2 investors.
SP500 0.3%DOW -0.0%FTSE 100 0.5%NIKKEI -0.3%OIL -0.3%GOLD -0.2%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

EV / EBITA for Vaccinex Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

VCNX: Vaccinex Inc

Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The ...

1.00 USD
Price
– USD
Fair Value
–
Upside
0.28 - 8.90
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Vaccinex Inc's EV / EBITA:

Dec 2015Dec 2017Dec 2019Dec 2021Dec 2023-3.0x-2.5x-2.0x-1.5x-1.0x-0.5x
Performance Summary
  • Vaccinex's latest twelve months ev / ebita is 0.0x
  • Vaccinex's ev / ebita for fiscal years ending December 2019 to 2023 averaged -1.4x.
  • Vaccinex's operated at median ev / ebita of -1.3x from fiscal years ending December 2019 to 2023.
  • Looking back at the last 5 years, Vaccinex's ev / ebita peaked in September 2024 at 0.0x.
  • Vaccinex's ev / ebita hit its 5-year low in December 2019 of -2.6x.
  • Vaccinex's ev / ebita decreased in 2019 (-2.6x, +65.7%) and 2022 (-1.3x, +49.1%) and increased in 2020 (-2.2x, -14.8%), 2021 (-0.8x, -61.3%), and 2023 (-0.4x, -70.6%).

How does Vaccinex's EV / EBITA benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Vaccinex Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Vaccinex EV / EBITA Benchmarks
NameTickerEV / EBITA
Akebia TherNASDAQCM:AKBA-57.6x
Cytokinetics IncNASDAQGS:CYTK-7.7x
Umbra Companies IncOTCPK:ZEOX-2.9x
Curis IncNASDAQCM:CRIS-0.8x
HealthcareSECTOR:HLTH.US-0.6x
Agios PharmNASDAQGS:AGIO-0.2x
Vaccinex IncOTCPK:VCNX0.0x
Fate Therapeutics IncNASDAQGM:FATE0.5x
Relay Therapeutics IncNASDAQGM:RLAY0.8x
Neurogene IncNASDAQGM:NGNE1.5x
I MabNASDAQGM:IMAB1.8x
Alector IncNASDAQGS:ALEC1.8x

Metric Usage: EV / EBITA

Hide this widget
ev_to_ebita_ltm
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EV / EBITA in the valuation category include:

View Full List

Search for metric or datapoint

EV / EBITA

Measures the dollars in Enterprise Value for each dollar of EBITA over the last twelve months.

Definition of EV / EBITA

Hide this widget
Measures the dollars in Enterprise Value for each dollar of EBITA over the last twelve months.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-93.2x-48.2x-3.2x79.4x100300500700

The chart above depicts the distribution of ev / ebita for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,356 had meaningful values. The average ev / ebita of companies in the sector is 0.4x with a standard deviation of 17.0x.

Vaccinex Inc's EV / EBITA of 0.0x ranks in the 59.4% percentile for the sector. The following table provides additional summary stats:

EV / EBITA In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,454
Included Constituents2,356
Min-93.6x
Max78.0x
Median-0.7x
Mean0.4x
Standard Deviation17.0x

You can find companies with similar ev / ebita using this stock screener.

All rights reserved. Terms Of Use